Teva Pharmaceutical Industries Limited Net Cash Used For Investing Activities for the year ending December 31, 2024: USD 792.00 M

Teva Pharmaceutical Industries Limited Net Cash Used For Investing Activities is USD 792.00 M for the year ending December 31, 2024, a -18.18% change year over year. Net cash used for investing activities is total cash inflows and outflows related to activities intended to generate future income and cash flows from investments.
  • Teva Pharmaceutical Industries Limited Net Cash Used For Investing Activities for the year ending December 31, 2023 was USD 968.00 M, a 47.56% change year over year.
  • Teva Pharmaceutical Industries Limited Net Cash Used For Investing Activities for the year ending December 31, 2022 was USD 656.00 M, a -56.93% change year over year.
  • Teva Pharmaceutical Industries Limited Net Cash Used For Investing Activities for the year ending December 31, 2021 was USD 1.52 B, a 76.48% change year over year.
  • Teva Pharmaceutical Industries Limited Net Cash Used For Investing Activities for the year ending December 31, 2020 was USD 863.00 M, a 100.70% change year over year.
Key Data
Date Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities Depreciation And Amortization Dividends Paid